Bobulsky Susan
Chief Commercial Officer, MRD at ADPT
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Sep 15, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ADPTAdaptive Biotechnologies CorpChief Commercial Officer, MRD
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ADPTRoutineJun 4, 2026 2026
Sold 11,000 shares at $18.00 ($198k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 2.6% of holdings ($7.7M position)416,775 shares leftFiling
- 2 Form 4 sale ADPTRoutineJun 11, 2026 +7 days
Sold 5,000 shares at $19.00 ($95k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 1.2% of holdings ($7.9M position)411,775 shares left0.2x usual sizeFiling
- 3 Form 4 sale ADPTRoutineJun 25, 2026 +14 days
Sold 5,000 shares at $20.50 ($103k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 1.2% of holdings ($8.4M position)406,775 shares left0.3x usual sizeFiling
- 4 Form 4 sale ADPTRoutineJul 1, 2026 +6 days
Sold 487 shares at $22.00 ($11k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 0.1% of holdings ($8.9M position)406,288 shares left0x usual sizeFiling
- 5 Form 4 sale ADPTRoutineJul 16, 2026 +15 days
Sold 5,000 shares at $23.00 ($115k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 1.2% of holdings ($9.3M position)401,288 shares left0.6x usual sizeFiling
- 6 Form 4 sale ADPTRoutineJul 30, 2026 +14 days
Sold 1,299 shares at $24.00 ($31k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 0.3% of holdings ($9.6M position)399,989 shares left0.3x usual sizeFiling
- 7 Form 4 sale ADPTRoutineAug 10, 2026 +11 days
Sold 3,000 shares at $25.00 ($75k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 0.8% of holdings ($10M position)396,989 shares left0.6x usual sizeFiling
- 8 Form 4 sale ADPTRoutineSep 15, 2026 +36 days
Sold 1,195 shares at $27.00 ($32k)
Bobulsky Susan, Chief Commercial Officer, MRD
10b5-1 planSold 0.3% of holdings ($10.7M position)395,794 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 17, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 1,195 | $32k | 0.3% | Routine | SEC |
| Aug 10, 2026 | Aug 12, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 3,000 | $75k | 0.8% | Routine | SEC |
| Jul 30, 2026 | Aug 3, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 1,299 | $31k | 0.3% | Routine | SEC |
| Jul 16, 2026 | Jul 20, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 5,000 | $115k | 1.2% | Routine | SEC |
| Jul 1, 2026 | Jul 6, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 487 | $11k | 0.1% | Routine | SEC |
| Jun 25, 2026 | Jun 29, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 5,000 | $103k | 1.2% | Routine | SEC |
| Jun 11, 2026 | Jun 15, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 5,000 | $95k | 1.2% | Routine | SEC |
| Jun 4, 2026 | Jun 8, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 11,000 | $198k | 2.6% | Routine | SEC |
| Mar 16, 2026 | Mar 16, 2026 | ADPT | Officer | Form 144 notice | 41,338 | $600k | Notice | SEC | |
| Mar 11, 2026 | Mar 13, 2026 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 41,338 | $544k | 8.8% | No plan | SEC |
| Mar 5, 2025 | Mar 6, 2025 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 26,023 | $182k | 7.0% | No plan | SEC |
| Mar 5, 2024 | Mar 6, 2024 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 12,991 | $45k | 5.0% | No plan | SEC |
| Dec 10, 2020 | Dec 11, 2020 | ADPT | SVP, Diagnostics, clonoSEQ | Form 4 sale | 25,000 | $1.4M | 100.0% | Unusual | SEC |
| Sep 29, 2020 | Oct 1, 2020 | ADPT | SVP, Diagnostics, clonoSEQ | Form 4 sale | 10,000 | $500k | 100.0% | Unusual | SEC |